{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:01:10Z","timestamp":1772816470747,"version":"3.50.1"},"reference-count":12,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,12,1]]},"abstract":"<jats:title>This Policy Statement was retired October 2003.<\/jats:title>\n               <jats:p>Since 1997, when the American Academy of Pediatrics (AAP) initially recommended expanded use of inactivated poliovirus vaccine (IPV) for routine childhood immunization against poliovirus infection, the occurrence of vaccine-associated paralytic poliomyelitis (VAPP) has decreased in the United States. However, VAPP will not be eliminated until oral poliovirus vaccine (OPV) no longer is given. As a result of continuing progress toward global eradication of poliomyelitis, the risk of imported infection has continued to decrease. Concomitantly, the use of IPV has increased substantially with the corresponding decrease in the use of OPV, indicating widespread acceptance by health care professionals and parents of the sequential or all-IPV immunization schedule previously recommended by the AAP. In addition, availability of OPV will be substantially diminished beginning in early 2000. To eliminate VAPP in the context of decreasing risk of wild-type poliovirus importation, the AAP recommends an all-IPV schedule for routine childhood immunization beginning in early 2000. The AAP further recommends that, effective immediately, OPV no longer should be purchased for routine use. Guidelines are given for utilization of remaining supplies of OPV during the transition in early 2000 to the all-IPV schedule.<\/jats:p>","DOI":"10.1542\/peds.104.6.1404","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:45:45Z","timestamp":1092440745000},"page":"1404-1406","source":"Crossref","is-referenced-by-count":56,"title":["Prevention of Poliomyelitis: Recommendations for Use of Only Inactivated Poliovirus Vaccine for Routine Immunization"],"prefix":"10.1542","volume":"104","author":[{"name":"Committee on Infectious Diseases","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[1999,12,1]]},"reference":[{"key":"2023081714055216000_B1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1542\/peds.99.2.300","article-title":"Poliomyelitis prevention: recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine.","volume":"99","author":"American Academy of Pediatrics, Committee on Infectious Diseases","year":"1997","journal-title":"Pediatrics."},{"key":"2023081714055216000_B2"},{"key":"2023081714055216000_B3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1542\/peds.103.1.171","article-title":"Poliomyelitis prevention: revised recommendations for use of inactivated and live oral poliovirus vaccines.","volume":"103","author":"American Academy of Pediatrics, Committee on Infectious Diseases","year":"1999","journal-title":"Pediatrics."},{"key":"2023081714055216000_B4","first-page":"590","article-title":"Recommendations of the Advisory Committee on Immunization Practices: revised recommendations for routine poliomyelitis vaccination.","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2023081714055216000_B5"},{"key":"2023081714055216000_B6","first-page":"1017","article-title":"Impact of the sequential IPV\/OPV schedule on vaccination coverage levels\u2014United States, 1997.","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2023081714055216000_B7","first-page":"829","article-title":"National vaccination coverage levels among children aged 19\u201335 months\u2014United States, 1998.","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2023081714055216000_B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.104.2.e15","article-title":"Vaccines for Children Program, United States, 1997.","volume":"104","author":"Santoli","year":"1999","journal-title":"Pediatrics."},{"key":"2023081714055216000_B9"},{"key":"2023081714055216000_B10","first-page":"416","article-title":"Progress toward global poliomyelitis eradication\u20141997\u20131998.","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2023081714055216000_B11"},{"key":"2023081714055216000_B12"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/104\/6\/1404\/1519537\/pe129901404p.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/104\/6\/1404\/1519537\/pe129901404p.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T14:06:20Z","timestamp":1692281180000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/104\/6\/1404\/62661\/Prevention-of-Poliomyelitis-Recommendations-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12,1]]},"references-count":12,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1999,12,1]]},"published-print":{"date-parts":[[1999,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.104.6.1404","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[1999,12,1]]}}}